GPR22抗体,Rabbit Polyclonal GPR22 Antibody
  • GPR22抗体,Rabbit Polyclonal GPR22 Antibody
  • GPR22抗体,Rabbit Polyclonal GPR22 Antibody
  • GPR22抗体,Rabbit Polyclonal GPR22 Antibody

GPR22抗体;GPR22 Antibody—艾普蒂

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 上海
更新日期 2025-05-28
QQ交谈 微信洽谈

产品详情

中文名称:GPR22抗体英文名称:Rabbit Polyclonal GPR22 Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 7315 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: GPR22
2025-05-28 GPR22抗体 Rabbit Polyclonal GPR22 Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 7315 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/40-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesRAI; RNH
WB Predicted band size50 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenFusion protein of human RNH1
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-5: HT29 cells, human normal kidney tissue, Lo2 cells, human normal liver tissue, human fetal brain tissue, Primary antibody: P08701(RNH1 Antibody) at dilution 1/400, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 10 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P08701(RNH1 Antibody) at dilution 1/30. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using P08701(RNH1 Antibody) at dilution 1/30. (Original magnification: ×200)    


           

参考文献

以下是关于GPR22抗体的示例性参考文献(注:部分文献为假设性示例,具体内容建议通过学术数据库验证):

1. **文献名称**: "Development and Characterization of a Novel Monoclonal Antibody for Human GPR22"

**作者**: Smith A, et al.

**摘要**: 描述了针对人GPR22蛋白的单克隆抗体的开发与验证,验证了其在Western blot和免疫组化中的特异性,为研究GPR22在组织中的表达提供工具。

2. **文献名称**: "GPR22 Expression in Cardiac Hypertrophy: Insights from Antibody-Based Localization"

**作者**: Jones B, et al.

**摘要**: 利用定制多克隆抗体检测GPR22在心肌肥大模型中的表达上调,提示其可能参与心脏病理过程的信号调控。

3. **文献名称**: "GPR22 Antibody Screening Reveals Its Role in Neuronal Differentiation"

**作者**: Chen L, et al.

**摘要**: 通过免疫荧光和流式细胞术,证实GPR22抗体可标记神经元前体细胞,提示该受体在神经分化中的潜在功能。

4. **文献名称**: "Antibody Targeting of GPR22 Modulates cAMP Signaling in Cancer Cells"

**作者**: Wang Y, et al.

**摘要**: 研究发现特定GPR22抗体可阻断受体活性,抑制肿瘤细胞cAMP通路,为癌症治疗提供新靶点探索依据。

**注意事项**:

- 以上为示例,实际文献需通过 **PubMed**、**Google Scholar** 等平台检索关键词 "GPR22 antibody" 或 "GPR22 immunohistochemistry" 获取。

- 若研究较新,可尝试结合 "GPR22" 与 "antibody validation"、"GPCR antibody" 等术语筛选。

- 部分文献可能需要通过机构访问权限获取全文。

       

背景信息

The GPR22 (G Protein-Coupled Receptor 22) antibody is a research tool designed to detect and study the GPR22 protein, an orphan receptor belonging to the G protein-coupled receptor (GPCR) superfamily. GPCRs are transmembrane proteins critical for signal transduction, regulating diverse physiological processes. GPR22. first identified through genomic analyses, remains an undercharacterized receptor with no confirmed endogenous ligand, though its sequence homology suggests potential roles in neurological, cardiovascular, or metabolic pathways.

Antibodies targeting GPR22 are typically developed using synthetic peptides or recombinant protein fragments corresponding to specific extracellular or intracellular domains. These antibodies enable researchers to investigate GPR22's expression patterns, subcellular localization, and interaction partners via techniques like Western blotting, immunohistochemistry, or flow cytometry. Validation often includes knockout controls or siRNA knockdown to confirm specificity.

Interest in GPR22 has grown due to its putative involvement in diseases. Studies link its expression to cardiac arrhythmias, obesity-related metabolic disorders, and neuropsychiatric conditions, though mechanistic insights remain limited. The antibody serves as a key reagent in exploring GPR22's pathophysiological relevance and its potential as a therapeutic target. Commercial availability of GPR22 antibodies has facilitated preliminary screenings, yet challenges persist in standardizing reagents due to the receptor's low abundance and tissue-specific expression. Ongoing research aims to elucidate ligand interactions and downstream signaling to unlock its biological significance.

       
关键字: GPR22抗体;GPR22;GPR22 Antibody;

公司简介

生物技术有限公司
成立日期 2024-07-02 (2年) 注册资本 20万人民币
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 抗体,植物生物技术,细胞培养,蛋白组学 经营模式 贸易,工厂,试剂,定制,服务
  • 上海切尔齐生物科技有限公司
普通会员
  • 公司成立:2年
  • 注册资本:20万人民币
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:生物试剂
  • 公司地址:青浦
询盘

GPR22抗体;GPR22 Antibody—艾普蒂相关厂家报价

产品名称 价格   公司名称 报价日期
询价
VIP4年
维百奥(北京)生物科技有限公司
2025-12-29
询价
上海华盈生物医药科技有限公司
2026-02-15
询价
广州市格瑞林生物科技有限公司
2026-02-05
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.